{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-010354","form_type":"8-K","ticker":"AKTS","cik":"0002035832","company_name":"Aktis Oncology, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.081399+00:00","generated_at":"2026-05-16T10:58:33.163231+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aktis Oncology adopts classified board, supermajority vote, and eliminates written consent post-IPO","bullets":["Filed amended charter authorizing 480M shares of common, 10M Class A common, and 10M undesignated preferred stock.","Adopted classified board with staggered three-year terms; removal of directors requires two-thirds vote for cause.","Eliminated stockholder action by written consent in lieu of meetings.","Amended bylaws to establish procedures for stockholder proposals and director nominations.","All changes effective Jan 12, 2026 in connection with IPO completion, as previously disclosed in S-1."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-010354","json":"https://secwatch.observer/filing/0001193125-26-010354.json","markdown":"https://secwatch.observer/filing/0001193125-26-010354.md","text":"https://secwatch.observer/filing/0001193125-26-010354.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/d932945d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:58:33.163231+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"196d34ba06752b22feffe1a8bc60d0f2bb5eb083","claim":"Aktis Oncology, Inc.: Amended and restated bylaws to establish procedures for stockholder proposals and director nominations, modify indemnification provisions, and conform to amended charter (effective 2026-01-12).","evidence_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","confidence":0.9},{"claim_id":"6defbeaf19ec7063154f6dff122d4697f175a1c6","claim":"Aktis Oncology, Inc.: Amended and restated certificate of incorporation to authorize additional common/preferred stock, eliminate existing preferred series, change director removal vote threshold, establish classified board, and eliminate stockholder action by written consent (effective 2026-01-12).","evidence_excerpt":"on January 12, 2026, the Company filed its amended and restated certificate of incorporation (the “Amended and Restated Certificate”) with the Secretary of State of the State of Delaware. The Amended and Restated Certificate amends and restates the Company’s existing sixth amended and restated certificate of incorporation, as amended, in its entirety to, among other things: (i) authorize 480,000,000 shares of Common Stock and 10,000,000 shares of Class A common stock, par value $0.0001 per share; (ii) eliminate all references to the previously-existing series of preferred stock; (iii) authorize 10,000,000 shares of undesignated preferred stock that may be issued from time to time by the Company’s board of directors (the “Board”) in one or more series; (iv) require the approval of at least two-thirds of the shares entitled to vote to remove a director for cause; (v) establish a classified Board, as a result of which, the successors to the directors whose terms have expired will be elect","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001178253-26-000017","ticker":"SCYX","company_name":"SCYNEXIS INC","filed_at":"2026-05-29T20:01:37+00:00","headline":"SCYNEXIS effects 1:8 reverse stock split; authorized shares cut to 18.75M","event_type":"other","sec_items":["5.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001178253-26-000017","json":"https://secwatch.observer/filing/0001178253-26-000017.json","markdown":"https://secwatch.observer/filing/0001178253-26-000017.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178253/000117825326000017/0001178253-26-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178253/000117825326000017/scyx-20260528.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","comparable_excerpt":"On May 28, 2026, SCYNEXIS, Inc., a Delaware corporation (the “Company”), filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”), to effect a one-for-eight (1:8) reverse stock split of its outstanding common stock (the “Reverse Stock Split”) and a reduction in the total number of authorized shares of its common stock from 150,000,000 to 18,750,000, effective as of May 29, 2026 (the “Share Reduction”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825326000017/0001178253-26-000017-index.htm"}},{"accession":"0001193125-26-214680","ticker":"BAX","company_name":"BAXTER INTERNATIONAL INC","filed_at":"2026-05-08T23:59:59+00:00","headline":"Baxter shareholders approve charter amendment and incentive plan; board adopts new executive severance plan","event_type":"other","sec_items":["5.02","5.07","5.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-214680","json":"https://secwatch.observer/filing/0001193125-26-214680.json","markdown":"https://secwatch.observer/filing/0001193125-26-214680.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/10456/000119312526214680/0001193125-26-214680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10456/000119312526214680/d24051d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","comparable_excerpt":"the Board approved a corresponding amendment and restatement of the Company’s Amended and Restated Bylaws (the “Amended Bylaws”) reflecting that the number of directors on the Board shall not be less than seven nor more than twelve","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/10456/000119312526214680/0001193125-26-214680-index.htm"}},{"accession":"0001767042-26-000037","ticker":"KGS","company_name":"Kodiak Gas Services, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Kodiak shareholders approve board declassification and supermajority removal","event_type":"other","sec_items":["5.03","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001767042-26-000037","json":"https://secwatch.observer/filing/0001767042-26-000037.json","markdown":"https://secwatch.observer/filing/0001767042-26-000037.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1767042/000176704226000037/0001767042-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1767042/000176704226000037/kgs-20260507.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","comparable_excerpt":"At the 2026 Annual Meeting of Shareholders (the “Annual Meeting”) of Kodiak Gas Services, Inc. (the “Company”) held on May 7, 2026, the Company’s shareholders approved certain amendments (the “Charter Amendments”) to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) to (i) phase in declassification of the Board of Directors (the “Board”) and (ii) eliminate certain supermajority voting requirements and other obsolete provisions.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1767042/000176704226000037/0001767042-26-000037-index.htm"}},{"accession":"0001193125-26-251689","ticker":"SCHW","company_name":"SCHWAB CHARLES CORP","filed_at":"2026-06-01T21:00:25+00:00","headline":"Charles Schwab files Certificate of Elimination for Series I Preferred Stock","event_type":"other","sec_items":["5.03","9.01"],"materiality_score":0.15,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251689","json":"https://secwatch.observer/filing/0001193125-26-251689.json","markdown":"https://secwatch.observer/filing/0001193125-26-251689.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/316709/000119312526251689/0001193125-26-251689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/316709/000119312526251689/d143555d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","comparable_excerpt":"On June 1, 2026, The Charles Schwab Corporation (the “Company”) filed a Certificate of Elimination with the Secretary of State of the State of Delaware with respect to the Company’s 4.000% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series I (“Series I Preferred Stock”), which, effective upon filing, eliminated from the Company’s Fifth Restated Certificate of Incorporation, as amended, all matters set forth in the Certificate of Designations for the Series I Preferred Stock.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/316709/000119312526251689/0001193125-26-251689-index.htm"}},{"accession":"0001395942-26-000022","ticker":"OPLN","company_name":"OPENLANE, Inc.","filed_at":"2026-05-29T17:57:10+00:00","headline":"OPENLANE eliminates Series A Convertible Preferred Stock from charter","event_type":"other","sec_items":["5.03","9.01"],"materiality_score":0.2,"calibrated_materiality_score":0.2,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001395942-26-000022","json":"https://secwatch.observer/filing/0001395942-26-000022.json","markdown":"https://secwatch.observer/filing/0001395942-26-000022.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1395942/000139594226000022/0001395942-26-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1395942/000139594226000022/kar-20260529.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","comparable_excerpt":"On May 29, 2026, OPENLANE, Inc. (the “Company”) filed a Certificate of Elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware effecting the elimination of the Certificate of Designations relating to the Company’s Series A Convertible Preferred Stock (the “Series A Preferred Stock”) previously filed by the Company with the Secretary of State of the State of Delaware on June 9, 2020.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1395942/000139594226000022/0001395942-26-000022-index.htm"}},{"accession":"0000014707-26-000070","ticker":"CAL","company_name":"CALERES INC","filed_at":"2026-05-28T21:22:24+00:00","headline":"Caleres reduces board size from 11 to 10; shareholders re-elect all directors and approve compensation plan","event_type":"other","sec_items":["5.03","5.07","9.01"],"materiality_score":0.1,"calibrated_materiality_score":0.1,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0000014707-26-000070","json":"https://secwatch.observer/filing/0000014707-26-000070.json","markdown":"https://secwatch.observer/filing/0000014707-26-000070.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/14707/000001470726000070/0000014707-26-000070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/14707/000001470726000070/cal-20260528x8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","comparable_excerpt":"On May 28, 2026, the Board of Directors amended Article II, Section 1 of the Company’s Bylaws to decrease the number of directors from eleven to ten, effective May 28, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/14707/000001470726000070/0000014707-26-000070-index.htm"}},{"accession":"0001213900-26-062184","ticker":"RLMD","company_name":"RELMADA THERAPEUTICS, INC.","filed_at":"2026-05-28T20:59:47+00:00","headline":"Relmada increases authorized common shares to 200M; stockholders approve 2021 Plan amendment","event_type":"other","sec_items":["5.03","5.07","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062184","json":"https://secwatch.observer/filing/0001213900-26-062184.json","markdown":"https://secwatch.observer/filing/0001213900-26-062184.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/0001213900-26-062184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/ea0292521-8k_relmada.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","comparable_excerpt":"On May 28, 2026, Relmada Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of Nevada to increase the number of authorized shares of the Company’s common stock from 150,000,000 to 200,000,000 shares (the “ Charter Amendment ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/0001213900-26-062184-index.htm"}},{"accession":"0001437749-26-018579","ticker":"SLE","company_name":"Super League Enterprise, Inc.","filed_at":"2026-05-27T20:31:43+00:00","headline":"Super League Enterprise cancels Series AA Preferred Stock designation","event_type":"other","sec_items":["3.03","5.03","9.01"],"materiality_score":0.05,"calibrated_materiality_score":0.05,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018579","json":"https://secwatch.observer/filing/0001437749-26-018579.json","markdown":"https://secwatch.observer/filing/0001437749-26-018579.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621672/000143774926018579/0001437749-26-018579-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621672/000143774926018579/slgg20260527_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/0001193125-26-010354-index.htm","comparable_excerpt":"On May 22, 2026 (the “ Effective Date ”), Super League Enterprise, Inc. (the “ Company ”) filed a Cancellation of Certificate of Designation with the Secretary of State of the State of Delaware to terminate the designation of its Series AA Preferred Stock (the “ Certificate of Cancellation ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621672/000143774926018579/0001437749-26-018579-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}